- Home
- ARVN vs BTX Comparison
ARVN vs BTX Comparison
Compare ARVN & BTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ARVN | BTX |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 806.0M | 756.3M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | ARVN | BTX |
|---|---|---|
| Price | $12.16 | $6.71 |
| Analyst Decision | Buy | |
| Analyst Count | 23 | 0 |
| Target Price | ★ $17.89 | N/A |
| AVG Volume (30 Days) | ★ 1.0M | 844.6K |
| Earning Date | 02-10-2026 | 11-01-2025 |
| Dividend Yield | N/A | ★ 13.43% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $312,300,000.00 | N/A |
| Revenue This Year | $11.17 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 93.86 | N/A |
| 52 Week Low | $5.90 | $5.10 |
| 52 Week High | $21.00 | $8.31 |
Technical Indicators
Market Signals| Indicator | ARVN | BTX |
|---|---|---|
| Relative Strength Index (RSI) | 52.88 | 52.87 |
| Support Level | $11.86 | $6.35 |
| Resistance Level | $12.50 | $6.75 |
| Average True Range (ATR) | 0.53 | 0.12 |
| MACD | -0.12 | 0.02 |
| Stochastic Oscillator | 39.41 | 78.57 |
Price Performance
Historical ComparisonAbout ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About BTX BlackRock Technology and Private Equity Term Trust
BlackRock Technology and Private Equity Term Trust objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust will invest in equity securities issued by mid - and small capitalization companies that the Trust's adviser believes have above-average earnings growth potential.